Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Institution of Engineering and Technology announces 16 Honorary Fellows to mark its 150th year. Professor Stride was awarded the Fellowship in recognition of her contribution to biomedical engineering and research into treatment of major diseases.

Professor Eleanor Stride

Professor Eleanor Stride is one of sixteen world-leading engineers and technologists who have been awarded an Honorary Fellowship from the Institution of Engineering and Technology (IET) for their outstanding contribution to the engineering and technology industry. Professor Stride is Professor of Biomaterials at NDORMS and will lead the new Marcella Botnar wing opening in Summer 2021.

Professor Stride was awarded the Fellowship in recognition of her contribution to biomedical engineering and research into the treatment of major diseases. She says, “Receiving an Honorary Fellowship from the IET was the most wonderful surprise. I’m delighted and honoured and immensely grateful to the IET for its exceptional support of engineering across all its different branches”.

The announcement includes other pioneering female engineers and leading technologists including Kimberly Bryant, Founder of Black Girls CODE, Dr Anne-Marie Imafidon, Co-founder and CEO of Stemettes and TV personality Dr Hannah Fry, Associate Professor in the Mathematics of Cities.

On awarding the Honorary Fellowships, Professor Danielle George MBE, IET President, said: “I am delighted that we are able to mark the outstanding achievements of these talented individuals in our 150th year, with one of the IET’s highest honours, Honorary Fellowship. As distinguished engineers and technologists, they have each excelled in their professions and have made a vast contribution as pioneers of important areas in the engineering and technology industries. They should all be very proud of their achievements – with each award being extremely well-deserved.”

The awards will be officially given during Danielle George’s inaugural President’s Address ‘150 years of difference makers’ which takes place online today at 1pm.

Similar stories

Small mechanical forces in immune cells measured at unprecedented sensitivity

Kennedy Main Research

Oxford researchers have used advanced microscopy techniques to measure previously unseen forces generated by cells during an immune response; a breakthrough for mechanobiology and future advances in health and disease.

NDORMS researchers awarded for Dupuytren research

Awards Hand Kennedy Main

Three NDORMS researchers have received awards from the International Dupuytren Society, a patient organisation that brings together Dupuytren Disease patient societies from across the world.

Hope for rheumatoid arthritis patients who are non-responsive to anti-TNF

Arthritis Kennedy Main

New research published in The Lancet shows that tocilizumab is a more effective treatment than rituximab for rheumatoid arthritis patients with a poor response to anti-tumour necrosis factor (TNF).

A new study maps the expression of innate immune receptors during the course of arthritis

Arthritis Kennedy Main

The research, which was a collaboration with researchers from Oxford University and Queen Mary University of London and published in Journal of Autoimmunity, looked at changes in receptors known as toll-like receptors (TLRs) in arthritis at different stages of disease.

International Women's Day

Department Main

It’s International Women's Day! This year’s theme is #Choosetochallenge. We’re celebrating some of the amazing women at NDORMS, and asking them what changes they’d like to see in medical sciences over the next 100 years.

Patients and carers invited to join new group helping to shape research and treatment of bones, muscles and joints

Main PPI

Oxford’s newest patient partner group, OPEN ARMS launches today to explore the causes, treatment and care for patients with musculoskeletal conditions. Its first three patient partners explain why they are involved and invite other members of the public to join the team.